Next-Generation Phenotypic Screening in Early Drug Discovery for Infectious Diseases

Area of Science:

• Drug discovery and development
• Cell biology
• Infectious diseases

Background:

• Cell-based phenotypic screening is valuable for modeling biological conditions like host-pathogen interactions.
• Its methodological complexity limits high-throughput application and target identification, hindering conventional drug discovery.

Purpose of the Study:

• To review current and emerging technologies for phenotypic screening.
• To explore strategies for leveraging screening complexity in drug discovery.
• To enhance the utility of phenotypic screening for translational drug discovery.

Main Methods:

• Review of state-of-the-art and emerging technologies in cellular, molecular, and bioinformatics.
• Analysis of how these advances address the limitations of traditional phenotypic screening.

Main Results:

• Advances in cellular, molecular, and bioinformatics are converging.
• These technologies offer new strategies to harness the complexity of phenotypic screening.
• Phenotypic screening complexity can be transformed from a hindrance into a catalyst for discovery.

Conclusions:

• Emerging technologies can overcome the limitations of traditional phenotypic screening.
• Complexity in phenotypic screening can be leveraged for more effective drug discovery.
• This approach holds significant promise for developing new chemotherapeutics for infectious diseases.